Document is current
Any future updates will be listed below
-
Authors
Lee, Boyoung https://orcid.org/0000-0001-9445-510X
Pothula, Santosh https://orcid.org/0000-0002-8019-3396
Wu, Min
Kang, Hyeyeon https://orcid.org/0000-0002-2405-018X
Girgenti, Matthew J. https://orcid.org/0000-0003-1647-326X
Picciotto, Marina R. https://orcid.org/0000-0002-4404-1280
DiLeone, Ralph J. https://orcid.org/0000-0002-4770-2590
Taylor, Jane R.
Duman, Ronald S. https://orcid.org/0000-0001-8690-8439
-
Funding
Funding for this research was provided by:
Institute for Basic Science (IBS-R001-D2)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH077681)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH093897)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 21 April 2021
Revised: 4 February 2022
Accepted: 22 February 2022
First Online: 14 April 2022
Competing interests
: RSD consulted and/or received research support from Allergan, Naurex, Aptinyx, Sunovian, Eli Lilly, Johnson & Johnson, Taisho, Relmada, and Navitor. The remaining authors have no competing interests to declare.
